Contributor Page
Singh & Associates
Email  |  Website  |  Articles
Contact Details
Tel: +91 11 46667000
Fax: +91 11 46667001
E-337, East of Kailash
New Delhi
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
By Aishani Das, Prashant Daga
ThePvPI is an administrative mechanism that has been developed for monitoring the safety of authorized medicinal products (for human use) and to detect any deviation in their risk-benefit balance.
By Rupesh Gupta
The Office of the Director General of Civil Aviation, Government of India, has issued the much-awaited Civil Aviation Requirements considering the use of Remotely Piloted Aircraft by civilians for several purposes ...
By Harsimran Singh
The share of domestic electronics production in India's GDP is 2.3%.
By Rupesh Gupta
India has been witnessing tremendous growth in telecom sector on account of its vast subscriber list.
By Manish Lakhawat
The Government recently introduced the Consumer Protection Bill, 2018, in the Lok Sabha to replace the Consumer Protection Act, 1986.
By Ruchika Darira
The present appeal before the Supreme Court was filed by the Appellant against the final judgment and order dated 01.09.2009
By Anjani Soni Wadhwa
It was further stated, "Informational privacy is a facet of the right to privacy.
By Kumar Deep
Food means any substance, whether processed, partially processed or unprocessed, which is intended for human consumption; and includes primary food, genetically modified or engineered food or ...
By Prashant Daga
Every International Commercial Arbitration (ICA) or International Arbitration (IA) deals with the multiple interactions of laws.
By Parth Rawal
In a commercial contract, a tender is procured upon estimation of prices of material and labor to be incurred in future.
By Singh & Associates
The CHMP has issued a negative recommendation for one drug Exondys, intended for the treatment of Duchenne muscular dystrophy.
By Singh & Associates
Cablivi was developed by Ablynx, a Sanofi company.
By Singh & Associates
The FDA granted the approval of Lumoxiti to AstraZeneca Pharmaceuticals.
By Singh & Associates
It is the first gene therapy to be recommended for approval for a retinal disease.
By Singh & Associates
The severity of national epidemics varies widely among countries.
Contributor's Topics